Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13.
BACKGROUND
Lantibiotics are small microbial peptide antibiotics that are characterized by the presence of the thioether amino acids lanthionine and methyllanthionine. Lantibiotics possess structural genes which encode inactive prepeptides. During maturation, the prepeptide undergoes posttranslational modifications including the introduction of rare amino acids as lanthionine and methyllanthione as well as the proteolytic removal of the leader. The structural gene (lanA) as well as the other genes which are involved in lantibiotic modification (lanM, lanB, lanC, lanP), regulation (lanR, lanK), export (lanT(P)) and immunity (lanEFG) are organized in biosynthetic gene clusters.


RESULTS
Sequence comparisons in the NCBI database showed that Bacillus licheniformis DSM 13 harbours a putative lantibiotic gene cluster which comprises two structural genes (licA1, licA2) and two modification enzymes (licM1, licM2) in addition to 10 ORFs that show sequence similarities to proteins involved in lantibiotic production. A heat labile antimicrobial activity was detected in the culture supernatant and a heat stabile activity was present in the isopropanol cell wash extract of this strain. In agar well diffusion assays both fractions exhibited slightly different activity spectra against Gram-positive bacteria. In order to demonstrate the connection between the lantibiotic gene cluster and one of the antibacterial activities, two Bacillus licheniformis DSM 13 mutant strains harbouring insertions in the structural genes of the modification enzymes licM1 and licM2 were constructed. These strains were characterized by a loss of activity in the isopropanol extract and substractive MALDI-TOF predicted masses of 3020.6 Da and 3250.6 Da for the active peptides.


CONCLUSIONS
In conclusion, B. licheniformis DSM 13 produces an antimicrobial substance that represents the two-peptide lantibiotic lichenicidin and that shows activity against a wide range of Gram-positive bacteria including methicillin resistant Staphylococcus aureus strains.
Dischinger
Jasmin
J
Institute of Medical Microbiology, Immunology and Parasitology, University of Bonn, Bonn, Germany.
Josten
Michaele
M
Szekat
Christiane
C
Sahl
Hans-Georg
HG
Bierbaum
Gabriele
G
D000595:Amino Acid Sequence; D000900:Anti-Bacterial Agents / Q000096:biosynthesis* / Q000737:chemistry / Q000494:pharmacology; D001407:Bacillus / Q000235:genetics / Q000378:metabolism*; D001430:Bacteriocins / Q000096:biosynthesis* / Q000737:chemistry / Q000494:pharmacology; D005798:Genes, Bacterial; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects; D008826:Microbial Sensitivity Tests; D008969:Molecular Sequence Data; D005810:Multigene Family; D017386:Sequence Homology, Amino Acid; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
D000900:Anti-Bacterial Agents; D001430:Bacteriocins; C546394:lichenicidin, Bacillus licheniformis
Annu Rev Microbiol. 2007;61:477-501
17506681
Appl Environ Microbiol. 1995 May;61(5):1706-13
7646007
Appl Environ Microbiol. 2004 Nov;70(11):6887-91
15528558
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4316-21
12642677
FEMS Microbiol Lett. 1995 Mar 15;127(1-2):121-6
7737474
Chem Biol. 2008 Oct 20;15(10):1035-45
18940665
Appl Microbiol Biotechnol. 2008 Feb;78(1):181-8
18046550
Eur J Biochem. 2000 Jul;267(13):4068-74
10866808
J Biol Chem. 2001 Jan 19;276(3):1772-9
11038353
Antimicrob Agents Chemother. 1985 May;27(5):836-40
4015073
Mol Microbiol. 1998 Aug;29(4):1029-38
9767571
Antimicrob Agents Chemother. 2006 Apr;50(4):1449-57
16569864
Biochemistry. 2007 May 22;46(20):5884-95
17469849
Mini Rev Med Chem. 2007 Dec;7(12):1236-47
18220976
Mol Microbiol. 2005 Dec;58(5):1368-80
16313622
J Antibiot (Tokyo). 1992 Jun;45(6):832-8
1500347
Appl Environ Microbiol. 1998 Dec;64(12):4803-8
9835565
Curr Pharm Biotechnol. 2009 Jan;10(1):2-18
19149587
J Biol Chem. 1999 Dec 31;274(53):37544-50
10608807
Genome Biol. 2004;5(10):R77
15461803
J Bacteriol. 1987 Dec;169(12):5452-8
2890620
J Mol Microbiol Biotechnol. 2004;7(4):204-11
15383718
Eur J Biochem. 1988 Oct 15;177(1):53-9
3181159
Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17243-8
17085596
Nucleic Acids Res. 2000 Nov 1;28(21):4317-31
11058132
Infect Immun. 1999 Aug;67(8):4268-71
10417203
Mol Microbiol. 2006 Feb;59(3):731-42
16420347
Antimicrob Agents Chemother. 2005 Jul;49(7):2606-11
15980326
Int J Med Microbiol. 2009 Jun;299(5):313-22
19138560
Appl Environ Microbiol. 2006 Nov;72(11):7270-7
16980420
Antimicrob Agents Chemother. 1998 Jan;42(1):154-60
9449277
Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11448-53
15277670
J Bacteriol. 1994 Dec;176(23):7335-44
7961506
Appl Environ Microbiol. 1996 Feb;62(2):385-92
8593044
FEMS Microbiol Lett. 2007 Feb;267(1):64-71
17233677
Curr Protein Pept Sci. 2005 Feb;6(1):77-84
15638770
J Bacteriol. 1985 May;162(2):833-6
3921529
Biochemistry. 2004 Mar 23;43(11):3049-56
15023056
FEMS Microbiol Lett. 2005 Nov 15;252(2):235-41
16194596
Mol Microbiol. 1995 Jun;16(5):969-76
7476193
Eur J Biochem. 1995 Sep 1;232(2):478-89
7556197
Biotechnol Prog. 1997 Nov-Dec;13(6):757-61
9413133
Appl Environ Microbiol. 2000 Jun;66(6):2565-71
10831439
Mol Microbiol. 2006 Nov;62(3):735-47
17076667
Eur J Biochem. 1986 Oct 1;160(1):9-22
3769923
Acta Microbiol Pol A. 1976;8(1):71-7
820164
Microbiology (Reading). 2001 Mar;147(Pt 3):643-651
11238971
N Engl J Med. 1988 Jul 21;319(3):157-61
2968517
Antimicrob Agents Chemother. 2005 Feb;49(2):541-8
15673730
Mol Microbiol. 2006 Jul;61(2):285-96
16771847
Microbiology (Reading). 2003 Jan;149(Pt 1):9-17
12576575
Appl Microbiol. 1971 May;21(5):943
4930039